Banner - Collaborative Care Symposium

Andrew R. Harrison, MD

Harrison is an associate professor in the Department of Ophthalmology and Visual Neurosciences, University of Minnesota in Minneapolis.

e:[email protected]

Articles by Andrew R. Harrison, MD

Advancement in TED treatment is a bright spot

ByAndrew R. Harrison, MD

June 30th 2021

FDA approval of teprotumumab as therapeutic offers hope for patients.

Latest Updated Articles

Advancement in TED treatment is a bright spot
Published: June 30th 2021 | Updated:

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program

US FDA awards Epion Therapeutics EpiSmart cross-linking system Fast Track designation

Treating myopia today: US-focused treatments, challenges, and global insights

© 2025 MJH Life Sciences^®

All rights reserved.